TENGION INC

Profile

Company Names

TENGION INC

Addresses

3929 WESTPOINT BLVD., SUITE G, WINSTON-SALEM, NC 27103

3929 WESTPOINT BLVD., SUITE G, WINSTON-SALEM, NC 27103

2900 POTSHOP LANE, SUITE 100, EAST NORRITON, PA 19403

Phone Numbers

336-722-5855
267-960-4800

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$121,663,531.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2013-06-28 
$74,304,002.00 
$74,304,002.00 
$0.00 
Debt 
3
2012-10-02 
$15,005,251.00 
$15,005,251.00 
$0.00 
Debt 
2
2012-09-07 
$1,000,000.00 
$1,000,000.00 
$0.00 
Debt 
1
2011-03-01 
$31,354,278.00 
$31,354,278.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
TIM 
 
BERTRAM 
EXECUTIVE OFFICER
TENGION INC
TIMOTHY 
 
BERTRAM 
DIRECTOR, EXECUTIVE OFFICER
TENGION INC   |  NEXIMMUNE, INC.
CARL-JOHAN 
 
DALSGAARD 
DIRECTOR
TENGION INC
A. 
BRIAN 
DAVIS 
EXECUTIVE OFFICER
TENGION INC   |  STRONGBRIDGE BIOPHARMA PLC
A. BRIAN 
 
DAVIS 
EXECUTIVE OFFICER
TENGION INC   |  STRONGBRIDGE BIOPHARMA PLC   |  GRACE THERAPEUTICS, INC.
SCOTT 
D. 
FLORA 
DIRECTOR
TENGION INC
BRENDA 
D 
GAVIN 
DIRECTOR
TENGION INC
DIANE 
 
JORKASKY 
DIRECTOR
TENGION INC   |  COMPLEXA INC.
RICHARD 
 
KUNTZ 
DIRECTOR
EPITEK, INC   |  TENGION INC   |  DIAMEDICA THERAPEUTICS INC.   |  COGNITO THERAPEUTICS LTD.   |  COGNITO THERAPEUTICS GROUP, INC.   |  ELUCID BIOIMAGING INC.
RICHARD 
E. 
KUNTZ 
DIRECTOR
TENGION INC
GARY 
J 
KURTZMAN 
DIRECTOR
TENGION INC
JOHN 
 
MICLOT 
EXECUTIVE OFFICER, DIRECTOR
BODYMEDIA INC   |  TENGION INC   |  BREATHE TECHNOLOGIES INC   |  LINGUAFLEX, INC.   |  BREATHE ACQUISITION CORP.   |  BREATHE TECHNOLOGIES, INC.
JOHN 
L. 
MICLOT 
EXECUTIVE OFFICER, DIRECTOR
EV3 INC.   |  TENGION INC   |  WRIGHT MEDICAL GROUP N.V.
STEVEN 
 
NICHTBERGER 
EXECUTIVE OFFICER, DIRECTOR
TENGION INC   |  INTELLIRAD CONTROL, INC.   |  CONTROLRAD SYSTEMS, INC.   |  CONTROLRAD, INC.   |  CABALETTA BIO, INC.
LORIN 
J 
RANDALL 
DIRECTOR
TENGION INC
LORIN 
J. 
RANDALL 
DIRECTOR
ATHERSYS, INC / NEW   |  TENGION INC   |  NANOSPHERE INC
DAVID 
 
SCHEER 
DIRECTOR
AEGERION PHARMACEUTICALS, INC.   |  TENGION INC   |  PLANIT IMPACT INC.   |  DNAMX, INC.   |  REFACTOR HEALTH, INC.   |  REVELAR BIOTHERAPEUTICS, INC.   |  THYRON PHARMACEUTICALS, INC.   |  ADELA, INC.   |  THIRDLAW MOLECULAR, INC.
DAVID 
I 
SCHEER 
DIRECTOR
TENGION INC
SUNITA 
 
SHETH 
EXECUTIVE OFFICER
TENGION INC
MARK 
 
STEJBACH 
EXECUTIVE OFFICER
TENGION INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-08-07
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2013-06-28 
2012-10-10
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Debt 
2012-10-02 
2012-09-21
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Debt 
2012-09-07 
2011-03-16
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2011-03-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
LOUIS J. ELLIS
4164953
ROTH CAPITAL PARTNERS, LLC
15407
NONE
NONE
PIPER JAFFRAY + CO.
665
NONE
NONE
LEERINK SWANN LLC
39011